Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity - Nakagama, Yu; Candray, Katherine; Kaku, Natsuko; Komase, Yuko; Rodriguez-Funes, Maria-Virginia; Dominguez, Rhina; Tsuchida, Tomoya; Kunishima, Hiroyuki; Nagai, Etsuko; Adachi, Eisuke; Ngoyi, Dieudonné Mumba; Yamasue, Mari; et al. (The Journal of infectious diseases, 2023)
Keywords: Antibodies, Neutralizing; Antibodies, Viral; Antibody Affinity; Avidity; BNT162 Vaccine; Coronaviruses; COVID-19; COVID-19 Serotherapy; Humans; Humoral immunity; Immunity; Immunoglobulin G; Major; Recovery (Medical); SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus; Urea; Vaccination; Vaccines; avidity; SARS-CoV-2; variants of concern; antibody maturation; neutralization breadth